Ruto: Cancer drug prices slashed sevenfold in Pfizer deal
President Ruto said the reduction would, in some cases, bring the cost of a single treatment cycle from as much as Sh1 million to below Sh50,000.
Kenya's President William Ruto announced a significant reduction in the cost of cancer drugs after signing an agreement with US pharmaceutical giant Pfizer. The deal, under Pfizer’s Accord for a Healthier World initiative, is expected to slash the price of medicines for various cancers, including breast, stomach, colon, lung, prostate, oesophageal, leukaemia, lymphoma, and multiple myeloma, by more than seven times.
This means that a single treatment cycle, previously costing up to Sh1 million, could now be as low as Sh50,000. The President emphasized that this reduction would alleviate the financial burden on cancer patients, making the Sh800,000 cancer package under the Social Health Authority (SHA) sufficient to cover treatment without additional costs.
Additionally, the agreement promises to address delays in accessing newer cancer medicines, with Kenya set to gain access to these treatments without the usual 10-year wait.
Brief written by urgent.news from Capital FM Kenya's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
